chartexchange

Kamada Updates on Withholding Tax Procedures on Previously Announced Cash Dividend to Shareholders

GlobeNewswire Inc. | Nov 19, 2026 4:01 PM EST

REHOVOT, Israel and HOBOKEN, N.J., Nov. 19, 2026 (GLOBE NEWSWIRE) -- Kamada Ltd. (the “Company”) (NASDAQ: KMDA; TASE: KMDA.TA), a global biopharmaceutical company with a portfolio of marketed products indicated for rare and serious conditions and a leader in the specialty plasma-derived field, announced today that it has obtained an extension of the previously granted tax ruling (the “Ruling”) from the Israel Tax Authority (the “ITA”) with respect to the cash dividend of $0.14 (approximately NIS 0.45) per share on the Company’s ordinary shares (totaling approximately $8.0 million) announced on November 9, 2026 (the “Dividend”), expected to be paid on December 9, 2026 (the “Payment Date”), to shareholders of record at the close of business on November 19, 2026 (the “Record Date”).

Read original article